Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PARK7/DJ1 Antikörper (AA 2-189)

PARK7 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
Produktnummer ABIN7427252
  • Target Alle PARK7/DJ1 (PARK7) Antikörper anzeigen
    PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))
    Bindungsspezifität
    • 25
    • 16
    • 12
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2-189
    Reaktivität
    • 96
    • 71
    • 52
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 98
    • 16
    • 2
    • 1
    Maus
    Klonalität
    • 95
    • 22
    Monoklonal
    Konjugat
    • 67
    • 11
    • 10
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PARK7/DJ1 Antikörper ist unkonjugiert
    Applikation
    • 92
    • 43
    • 31
    • 28
    • 24
    • 20
    • 16
    • 13
    • 13
    • 13
    • 5
    • 5
    • 5
    • 4
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Monoclonal Antibody to Parkinson Disease Protein 7 (PARK7)
    Spezifität
    The antibody is a mouse monoclonal antibody raised against PARK7. It has been selected for its ability to recognize PARK7 in immunohistochemical staining and western blotting.
    Kreuzreaktivität
    Schwein
    Aufreinigung
    Protein A + Protein G affinity chromatography
    Immunogen
    Recombinant Parkinson Disease Protein 7 (PARK7) corresdonding to Ala2~Asp189 with N-terminal His Tag
    Klon
    C1
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product PARK7 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-5 μg/mL Immunohistochemistry: 5-30 μg/mL Immunocytochemistry: 5-30 μg/mL Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))
    Andere Bezeichnung
    Parkinson Disease Protein 7 (PARK7 Produkte)
    Hintergrund
    DJ1, Autosomal Recessive,Early Onset
    Pathways
    Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Proton Transport
Sie sind hier:
Kundenservice